Pharmaceutical Technology

MAY 17, 2023

Both platforms use the company’s development, manufacturing and analytical capabilities in lentiviral vector (LVV) and adeno-associated viral vector (AAV). AGC Biologics’ proprietary procedure and capsid-based platform methods can speed up development timelines, thereby enabling the delivery of GMP products in nine months.

52

52

Express Pharma

APRIL 20, 2023

Continuous manufacturing The topic of continuous manufacturing is also discussed in frames of PHARMAP 2023. I think there are various different ways of development. Pharma biotech is a growing field in which the principles of biotechnology are applied to the development of drugs.

Packaging 52

Packaging Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

Quality Matters

APRIL 18, 2024

This includes a focus on ESG topics most relevant to USP’s operations, standard-setting activities, our stakeholders’ expectations and priorities, and – most importantly – where USP’s work can have a disproportionately positive impact. These USP documentary standards are recognized in U.S. Through the support of key donors including the U.S.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Generic Medicine 59

Quality Matters

MARCH 8, 2022

But thanks to the vaccines developed to fight the pandemic, mRNA, specifically mRNA vaccines, has become a topic of public interest. Quality testing is integral to the development and manufacturing processes. Non-scientists want to understand what mRNA vaccines are, how they work and whether they should trust them. What is mRNA?

Vaccines 52

Vaccines Immunity Immunization Packaging 52

Pharmaceutical Technology

AUGUST 17, 2022

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. It will also have the potential to scale to Phase III clinical development and commercial manufacturing.

Vaccines 52

Vaccines Drug Development 52

PharmaState Academy

DECEMBER 11, 2023

PharmaState.Academy in collaboration with Octavus Consulting organized a Masterclass on the Topic: Competitive Intelligence in the Pharma and Healthcare Landscape. They also discussed the CI landscape, a tool created by Aditya, which provides comprehensive information about products at various stages of development and in different markets.

Biosimilars 52

Biosimilars 52

ID Stewardship

FEBRUARY 25, 2024

In this article four experts from bioMérieux discuss microbiology strategies to advance antimicrobial stewardship, reflecting on a recent Xchat (Twitter Chat) on the topic. Pre-analytic: help provide education about appropriate test collection practices, support the lab in rejection of tests that don’t meet criteria.

Communication 83

Communication Hospitals 83

Quality Matters

NOVEMBER 11, 2022

FDA) workshop , my fellow panelist and I addressed the latest developments in the identification and control of nitrosamines in pharmaceutical products. The chapter provides recommendations on risk assessment and the development of detection and control strategies. Earlier this year, at a U.S. Food and Drug Administration (U.S.

Packaging 52

Packaging Documentation Compounding Diabetes 52

FDA Law Blog: Biosimilars

JUNE 22, 2023

This type of public spat does not instill confidence in companies developing or investing in OTC IVDs. To obtain clearance of an OTC home IVD, a sponsor must provide the usual suite of analytical and clinical validation that would be required for any IVD, demonstrating adequate repeatability, stability, sensitivity, specificity, and so on.

Labelling 59

Labelling Hospitals 59

Quality Matters

MAY 25, 2023

To address the issue, the FDA has collaborated with international regulators since 2018, sharing related scientific knowledge and current thinking on technical safety and quality topics, developing guidance, and issuing related public health alerts. Panelist Jason Bunting, Pharm.D.,

Communication 52

Communication 52

European Pharmaceutical Review

JANUARY 29, 2024

6 The CPCA is a pragmatic, science-based approach which ensures that control strategies are more deliverable as method sensitivity/robustness considerations are more easily addressed. 17 Accelerating drug development The first issue of 2023 , 18 dealt with accelerating drug development. 25 Sun et al. Arch Pharm DPhG.

Drug Development 94

Drug Development Vaccines Compounding 94

Pharmaceutical Technology

JUNE 15, 2023

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Overview of the drug development process Drug development is a complex and costly process that typically takes years to complete.

Drug Development 52

Drug Development Compounding Adverse Reactions Dosage 52

PharmaShots

MARCH 6, 2023

As a result of this progression, our industry developed the notion of patient-centricity. In combination with data-driven insights generation, our multi-faceted approach toward truly understanding patient needs will enable our teams to design and execute development plans for products that effectively address unmet needs.

Drug Development 40

Drug Development Immunity Immunization Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 23, 2022

I haven’t presented; I’m here mainly as the business team for some of our professional clients, but also partners as part of that topic, also. A lot within the conference agenda and presentation has been around outcomes, thinking about value and holistic methods and how to move that more from the commercial end.

Dosage 98

Dosage Documentation Hospitals Vaccines 98

European Pharmaceutical Review

FEBRUARY 23, 2023

Given the widely reported challenges of validation and qualification of microbiological methods, as well as lab compliance and keeping up with compendial amendments, I have steered away from these topics here. However, firms must establish if or how these platforms diverge from compendial methods and possible failure modes.

Dosage 92

Dosage Vaccines 92

ID Stewardship

JUNE 5, 2023

To shed light on this important topic, we had the privilege of interviewing an esteemed expert [ChatGPT by OpenAI] in the field of antimicrobial stewardship. Through their work, they have spearheaded initiatives, developed guidelines, and collaborated with diverse stakeholders to promote effective antimicrobial stewardship practices.

Vaccines 93

Vaccines Hospitals 93

ID Stewardship

AUGUST 1, 2023

Clinical pharmacy in Turkey is still developing. As the second year of my master’s education was close, I was in a hurry to decide on the topic and method for my master’s thesis with my advisor (Dr. In our hospital, local algorithms were developed, and the morning report application was launched in 2019.

Hospitals 84

Hospitals Community Pharmacies Dosage Communication 84

Quality Matters

MARCH 7, 2023

The complexity of the threat stems in part from the fact that pharmaceutical impurities can potentially form in a variety of ways during the life cycle of a drug’s development and manufacture. Our latest offering, the new Analytical Hub, is housed within USP’s Nitrosamines Exchange.

52

52

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Another major topic covered by the experts was technological advances. Miriam Guest, Principal Microbiologist at AstraZeneca.

Vaccines 125

Vaccines Research Laboratories Documentation Compounding 125

Quality Matters

MAY 24, 2023

Quality-focused solutions developed by USP to support availability and trust in the COVID-19 vaccines – and continuing adoption and evolution of the technologies for future applications – was a key focus of my address to WVC attendees.

Vaccines 52

Vaccines Documentation Immunity Immunization 52

Quality Matters

NOVEMBER 10, 2022

These include standards, R&D analytical solutions, and related programs that can help manufacturers ensure quality is built-in from the start. Implementing such innovation will take time, however, in part because of obstacles that some drug developers and manufacturers can face when considering whether to adopt PCM.

Drug Development 52

Drug Development 52

Quality Matters

AUGUST 18, 2023

Pharmacopeia (USP) is working to assist manufacturers considering adoption of PCM is by addressing potential technical barriers through development of guidelines, best practices and strategies that can help ensure the quality of medicines made with PCM technology. Control strategies are key elements of pharmaceutical development.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

MAY 10, 2023

Particle analysis on a micro-scale is a significant topic in several fields of application. Particle size is monitored in quality control as well as the development of active pharmaceutical ingredients (APIs). Among the most prominent methods are infrared (IR) imaging and single-point measurements.

52

52

PharmaShots

FEBRUARY 27, 2023

The sole purpose of the conference was to highlight the need to develop focus of the Indian pharma industry from majorly developing generics to marking its presence for innovation for the development of new products. Session 2: Panel Discussion Topic: Advanced Manufacturing Technologies Moderator: Ms.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Viseven

JULY 12, 2022

If you regularly google the equivalent topics to become a medical content ninja, you’re in the right place. Generate leads by inviting professionals and non-experts to online events to discuss various topics and trends. Write on multiple topics. Develop a Mobile App to Increase the Target Audience.

Communication 52

Communication Documentation Hospitals 52

Pharmaceutical Technology

JANUARY 6, 2023

It requires having access to proper techniques and skill sets, state-of-the-art equipment, process scientists and engineers who have a deep understanding of Quality by Design (QbD) principles, and methods for product and process characterisation. Expertise in analytical testing, validation, and quality control are also essential.

Dosage 52

Dosage Packaging Communication 52